AzTrials
AzTrials

HealthyRA1-2025NCT07876687

Reject Analysis of Periapical Radiographs of Dental Implants.

An observational study of Healthy, run by University Ghent at 1 site in Belgium.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Periapical radiographs of dental implants, acquired as part of two ongoing research projects, will be retrospectively analyzed using a newly developed image quality scoring form. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Healthy
How many people
49 participants
Where
1 siteBelgium
Study dates
1 Jan 2026to 1 Jul 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Fourty-nine fully edentulous patients, either in the upper- and/or lower jaw being treated with a bar-retained overdenture and werd seen at the yearly evaluation after 6 to 8 years of follow-up.

Who may be able to join

  • Patients which were treated with dental implants for a bar-retained overdenture in the upper - or lower jaw, as part of two running investigations.
  • Fully edentulous for minimally 4 months; Adequate bone volume to receive two or 4 implants

Who cannot join

  • <21 years old; Smoking

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Oral Health Sciences - Department of Periodontology and Oral Implantology - P8

    Ghent, Oost-Vlaanderen, 9000

Other trials in Belgium

About this study

Official title: Reject Analysis in Digital Dental Radiology: Diagnostic Quality Analysis of Peri-apical Radiographs of Dental Implants.

Periapical radiographs of dental implants, acquired as part of two ongoing research projects, will be retrospectively analyzed using a newly developed image quality scoring form. Following an initial classification (Excellent - Acceptable - Rejected), a detailed assessment of the various image quality criteria and any deviations from these criteria will be performed. In addition, the frequency with which radiographs had to be retaken to obtain a diagnostically acceptable image will be evaluated. The influence of anatomical factors (e.g., implant location in the mouth, maxilla or mandible, etc.) and the use of individualized radiographic holders will also be assessed.

Through this retrospective analysis of an existing dataset of implant radiographs, the study aims to identify the factors that have influenced image quality, the ability to accurately assess the surrounding bone level, and the need for repeat radiographic exposures. The findings may contribute to the development of guidelines to improve the quality of periapical radiographs and potentially reduce radiation exposure for patients.

Conditions
Healthy
Keywords
reject analysis, periapical radiograph, dental implants, quality analysis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07876687
Study groupRoleWhat they receive
Patients having received dental implants used for a bar-retained overdenture.Patients were treated with either 4 implants in the upper jaw or 2 implants in lower jaw as part of 2 running research projects. Periapical radiographs taken during these investigations will be analysed retrospectively .

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rejection classification

    The percentage of periapical radiographs classified as qualitatively excellent, acceptable or unacceptable.

    Measured: Through study completion, an average of 1 year.

  2. Repeat rate

    Number of radiographs which were actually repeated as result of unacceptable quality.

    Measured: Through study completion, an average of 1 year.

  3. Interexaminer reproducibility of the reject analysis.

    The degree of agreement between different examiners when classifying radiographs as rejected, acceptable or excellent, and when identifying the reasons for rejection according to the quality assessment criteria.

    Measured: Through study completion, an average of 1 year.

  4. Intra-examiner reproducibility

    The degree of agreement within the different examiners when classifying radiographs as rejected, acceptable or excellent, and when identifying the reasons for rejection according to the quality assessment criteria.

    Measured: Through study completion, an average of 1 year.

Secondary outcomes (1)
  1. Qualitative error classification

    Frequency analysis of errors resulting in the rejection of the radiographs.

    Measured: Through study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2026
  2. Study start1 Jan 2026
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07876687
Sponsor's protocol ID
ONZ-2025-0437
Acronym
RA1-2025
Status last verified
Oct 2026
First submitted
19 Sep 2026
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Sharing individual participant data will not be relevant for analysing the quality of the publication.

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rejection classification (time frame: Through study completion, an average of 1 year.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in